Authors:
LAMPETER EF
KLINGHAMMER A
SCHERBAUM WA
HEINZE E
HAASTERT B
GIANI G
KOLB H
Citation: Ef. Lampeter et al., THE DEUTSCHE-NICOTINAMIDE-INTERVENTION-STUDY - AN ATTEMPT TO PREVENT TYPE-1 DIABETES, Diabetes, 47(6), 1998, pp. 980-984
Authors:
KALLMANN BA
HUTHER M
TUBES M
FELDKAMP J
BERTRAMS J
GRIES FA
LAMPETER EF
KOLB H
Citation: Ba. Kallmann et al., SYSTEMIC BIAS OF CYTOKINE PRODUCTION TOWARD CELL-MEDIATED IMMUNE REGULATION IN IDDM AND TOWARD HUMORAL IMMUNITY IN GRAVES-DISEASE, Diabetes, 46(2), 1997, pp. 237-243
Citation: S. Martin et al., CURRENT TREATMENT STRATEGY FOR INSULIN-DE PENDENT DIABETES AND ITS PRECLINICAL STAGES, Der Internist, 37(12), 1996, pp. 1289-1304
Authors:
SEISSLER J
MORGENTHALER NG
ACHENBACH P
LAMPETER EF
GLAWE D
PAYTON M
CHRISTIE M
SCHERBAUM WA
Citation: J. Seissler et al., COMBINED SCREENING FOR AUTOANTIBODIES TO IA-2 AND ANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE IN FIRST DEGREE RELATIVES OF PATIENTS WITH IDDM, Diabetologia, 39(11), 1996, pp. 1351-1356
Authors:
LAMPETER EF
GURNIAK M
BROCKER U
KLEMENS C
TUBES M
FRIEMANN J
KOLB H
Citation: Ef. Lampeter et al., REGENERATION OF BETA-CELLS IN RESPONSE TO ISLET INFLAMMATION, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103, 1995, pp. 74-78
Authors:
MARTIN S
KARDORF J
SCHULTE B
LAMPETER EF
GRIES FA
MELCHERS I
WAGNER R
BERTRAMS J
ROEP BO
PFUTZNER A
PIETROPAOLO M
KOLB H
Citation: S. Martin et al., AUTOANTIBODIES TO THE ISLET ANTIGEN ICA-69 OCCUR IN IDDM AND IN RHEUMATOID-ARTHRITIS, Diabetologia, 38(3), 1995, pp. 351-355
Authors:
LAMPETER EF
TUBES M
KLEMENS C
BROCKER U
FRIEMANN J
KOLBBACHOFEN V
GRIES FA
Citation: Ef. Lampeter et al., INSULITIS AND ISLET-CELL ANTIBODY-FORMATION IN RATS WITH EXPERIMENTALLY REDUCED BETA-CELL MASS, Diabetologia, 38(12), 1995, pp. 1397-1404
Authors:
ACHENBACH P
SEISSLER J
LAMPETER EF
MAUCH L
SCHERBAUM WA
Citation: P. Achenbach et al., AUTOANTIBODIES TO GLUTAMIC-ACID DECARBOXYLASE IN 1312 1ST-DEGREE RELATIVES OF PATIENTS WITH TYPE-1 DIABETES, Diabetologia, 38, 1995, pp. 54-54
Authors:
BOHMER KP
KOLB H
KUGLIN B
ZIELASEK J
HUBINGER A
LAMPETER EF
WEBER B
KOLBBACHOFEN V
JASTRAM HU
BERTRAMS J
GRIES FA
Citation: Kp. Bohmer et al., LINEAR LOSS OF INSULIN SECRETORY CAPACITY DURING THE LAST 6 MONTHS PRECEDING IDDM - NO EFFECT OF ANTIEDEMATOUS THERAPY WITH KETOTIFEN, Diabetes care, 17(2), 1994, pp. 138-141
Authors:
LAMPETER EF
SEIFERT I
LOHMANN D
HEISE JW
BERTRAMS J
CHRISTIE MR
KOLBBACHOFEN V
KOLB H
Citation: Ef. Lampeter et al., INFLAMMATORY ISLET DAMAGE IN PATIENTS BEARING HLA-DR 3-HAPLOTYPE AND OR DR 4-HAPLOTYPE DOES NOT LEAD TO ISLET AUTOIMMUNITY/, Diabetologia, 37(5), 1994, pp. 471-475
Authors:
LAMPETER EF
HOMBERG M
QUABECK K
WERNER P
GRIES FA
KOLB H
Citation: Ef. Lampeter et al., ACCIDENTAL TRANSFER OF TYPE-I DIABETES-MELLITUS BY TRANSPLANTATION OFHLA-IDENTICAL BONE-MARROW, Medizinische Klinik, 88(4), 1993, pp. 272-274
Citation: Ef. Lampeter, INTERVENTION WITH NICOTINAMIDE IN PRE-TYPE-1 DIABETES - THE DEUTSCHE NIKOTINAMID INTERVENTIONSSTUDIE-DENIS, Diabete et metabolisme, 19(1BIS), 1993, pp. 105-109
Authors:
LAMPETER EF
HOMBERG M
QUABECK K
SCHAEFER UW
WERNET P
BERTRAMS J
GROSSEWILDE H
GRIES FA
KOLB H
Citation: Ef. Lampeter et al., TRANSFER OF INSULIN-DEPENDENT DIABETES BETWEEN HLA-IDENTICAL SIBLINGSBY BONE-MARROW TRANSPLANTATION, Lancet, 341(8855), 1993, pp. 1243-1244